Special Symposium “MIRAI” 5 MIRAI 5
3 28 10001030 1 1FG7G8 FJCS

Special Symposium “MIRAI” 6 MIRAI 6
3 28 11001230 1 1FG7G8 FJCS /COI
Keynote Lecture MIRAI
1 GE CEO
2
Special Lecture by International HonoraryMembers in 2021 (3)
(3)
March 28 (Sun) 9451015 Room 8 (G314315, 3F, North)
Chairperson Kyoichi MizunoFJCSMitsukoshi Health and Welfare Foundation, Tokyo
New Frontiers in Health: The Heart and The Brain
Valentin FusterCardiology, The Mount Sinai Hospital, New York, USA
Special Lecture 13 13 (Basic Res)
March 28 (Sun) 800830 Room 17 (G418419, 4F, North)
Chairperson Satoaki MatobaFJCSDepartment of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto
Mitochondria: Regulators of Life and Death
Elizabeth MurphyNational Institutes of Health, Bethesda, USA
Special Lecture 14 14 (IHD)
March 28 (Sun) 800830 Room 20 (F205206, 2F, Annex) Chairperson
Yasuo OkumuraDivision of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo Layered Plaque: Prevalence and Biological Significance
Ik-Kyung JangCardiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
March
28
AM
220
Special Lecture 15 15 (HF/CM)
March 28 (Sun) 840910 Room 17 (G418419, 4F, North)
Chairperson Issei KomuroFJCSDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo
HFpEF:Malady,Model,Mechanism
Joseph A. HillCardiology, University of Texas Southwestern Medical Center, Dallas, USA
Plenary Session 12 (Surg/SHD)
March 28 (Sun) 800930 Room 3 (G6, 1F, North)
Strategic Treatment for Heart Valve Disease: Catheter Interventional Treatment vs Less Invasive Cardiac
Surgery
Chairpersons Yoshiki SawaFJCSDivision of Cardiovascular Surgery, Department of Surgery, Graduate School of Medicine, Osaka University, Suita Kentaro HayashidaFJCSDepartment of Cardiology, Keio University School of Medicine, Tokyo
State-of-the-Art Evolution of Aortic andMitral Valve Surgery Techniques under the Competitive Pressures of
Transcatheter Therapeutics
Joseph WooDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, California, USA 1Cost-effective Analysis of Trans-catheter Aortic Valve Replacement in Patient with Severe
Symptomatic Aortic Stenosis: ProspectiveMulticenter Study
Makoto AmakiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita 2Current Issues and Challenges in Transcatheter Aortic Valve Implantation
Kentaro HayashidaFJCSDepartment of Cardiology, Keio University School of Medicine, Tokyo 3Clinical Outcomes ofMore than 1,000 TAVR Experiences for Aortic Stenosis; From the Analysis of
KMH TAVI Registry
Shinichi ShiraiDepartment of Cardiology, Kokura Memorial Hospital, Kitakyushu 4Outcomes ofMinimally Invasive Aortic Valve Replacement for Aortic Insufficiency
Minoru TabataTokyo Bay Urayasu Ichikawa Medical Center, Urayasu/Toranomon Hospital, Tokyo 5Future Perspective of Less Invasive Procedure for Aortic Valve Stenosis: Heart Team Experiences of
1375 Patients in 10 Years
Koichi TodaDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita
Plenary Session 13 (Emer/Med Policy/New Fields)
March 28 (Sun) 800930 Room 8 (G314315, 3F, North)
Up Date of Intensive Care for Cardiogenic Shock
Chairpersons Yoshio TaharaFJCSDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita Robert W. NeumarDepartment of Emergency Medicine, University of Michigan, Ann Arbor, USA
State-of-the-Art ECPR for Out-of-Hospital Cardiac Arrest in the United States
Robert W. NeumarDepartment of Emergency Medicine, University of Michigan, Ann Arbor, USA 1Temporal Trends in In-hospitalMortality andMechanical Circulatory Support in Patients with Acute
Myocardial Infarction -Lessons fromMIYAGI AMI Registry-
Jun TakahashiFJCSDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai 2OptimalManagement of Cardiogenic Shock: Delivering the Comprehensive, Collaborative, and
Multidisciplinary Care
Takeshi YamamotoDivision of Cardiovascular Intensive Care, Nippon Medical School Hospital, Tokyo/The Cardiac Care Unit Committee, the Japanese Society of Intensive Care Medicine
3The Indication andManagement Practices of Cardiogenic Shock Based on Our Experience of 70
IMPELLA Cases
Hidetoshi HattoriDepartment of Cardiology, Tokyo Women’s Medical University, Tokyo
March
28
AM
221
Oxygenation in Refractory Cardiogenic Shock
Kenichiro SawadaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita
Plenary Session 14 (PDC/Divers/PH)
March 28 (Sun) 800930 Room 14 (G412413, 4F, North)
Revisiting School Cardiac Screening
Chairpersons Yoshihide MitaniFJCSDepartment of Pediatrics, Mie University Graduate School of Medicine, Tsu Jonathan DreznerDepartment of Family Medicine, University of Washington, Seattle, USA
State-of-the-Art Cardiac Screening of Young Athletes in the US: Time for a Risk-based Approach?
Jonathan DreznerDepartment of Family Medicine, University of Washington, Seattle, USA 1Contribution and Improvement of Heart Disease Screening for School Students
Mamoru AyusawaDepartment of Pediatrics, Nihon University School of Medicine, Tokyo 2Deep Learning-based Analysis of 12-lead Electrocardiogram for Pediatric Cardiac DiseaseMass
Screening in School-age Children
Shuhei TobaDepartment of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu 3Food and Nutrition Education for the Prevention of Lifestyle-related Disease and Cardiovascular
Disease
Atsushi SakimaHealth Administration Center, University of the Ryukyus, Okinawa 4Universal Screening for Children and Community Health Systems to Detect Familial
Hypercholesterolemia in Kagawa
Plenary Session 15 (Basic Res)
March 28 (Sun) 800930 Room 16 (G416417, 4F, North)
Recent Advance of Cardiovascular Regeneration Research
Chairpersons Keiichi FukudaFJCSDepartment of Cardiology, Keio University School of Medicine, Tokyo Charles MurryLaboratory Medicine and Pathology, University of Washington, Seattle, USA
State-of-the-Art Modulation of Engraftment Arrhythmia Following Transplantation of Stem Cell-Derived
Cardiomyocytes
Charles MurryLaboratory Medicine and Pathology, University of Washington, Seattle, USA 1Cardiac Regenerative Therapy with Human Induced Pluripotent Stem Cells for Heart Failure
Shugo TohyamaDepartment of Cardiology, Keio University School of Medicine, Tokyo 2Generation ofMature Cardiomyocytes from Pluripotent Stem Cells and Their Biomedical
Applications
Yoshinori YoshidaDepartment of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto
3YAP/TAZ and Fibrosis: New Link between Cardiac Reprogramming andMechanobiology
Masaki IedaDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba City
Symposium 17 (Stroke/Vasc)
March 28 (Sun) 800930 Room 5 (G303, 3F, North)
Forefront of Revascularization, Exercise and Pharmacotherapy for Peripheral Arterial Disease
Chairpersons Takanori YasuFJCSDokkyo Medical University Nikko Medical Center, Nikko Mary M. McDermottInternal Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA
Keynote Lecture Forefront of Revascularization, Exercise and Pharmacotherapy for Peripheral Arterial Disease
Mary M. McDermottInternal Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA
March
28
AM
222
Makoto ShojiDepartment of Cardiology, Showa University Fujigaoka Hospital, Yokohama 2Efficacy of Comprehensive Cardiovascular Rehabilitation for Peripheral Arterial Disease
Hiromitsu TsuchidaDepartment of Cardiovascular Surgery, Seijunkai Mito Hospital, Mito 3Roles of Angioplasty with Drug-Coated Balloon for Chronic Ischemia in Wound Healing -One-year
Outcomes of RADISH Study-
Yosuke HataCardiovascular Center, Kansai Rosai Hospital, Amagasaki 4Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions
Yasutaka YamauchiCardiovascular Center, Takatsu General Hospital, Kanagawa 5Association between Aortic Plaque on Non-obstructive General Angioscopy and Adverse Vascular
Events in Patients with Cardiovascular Disease
Keisuke KojimaDivision of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo 6Angiogenetic Gene Therapy with Hepatocyte Growth Factor Plasmid in Patients with Chronic Limb-
threatening Ischemia
Symposium 18 (HF/CM)
March 28 (Sun) 800930 Room 13 (G401402, 4F, North)
Current Status and Future Concern of Non-pharmacological Therapy to Heart Failure among Super
Aging Society
Chairpersons Koichiro KinugawaFJCSThe Second Department of Internal Medicine, University of Toyama, Toyama JoAnn LindenfeldCardiology, Vanderbilt University Medical Center, USA
Keynote Lecture Current Status and Future of Non-Pharmacologic Therapy in Heart Failure in a Super Aging Society
JoAnn LindenfeldCardiology, Vanderbilt University Medical Center, USA 1Catheter Ablation of Atrial Fibrillation after Heart Failure Hospitalization could Improve the
Prognosis in Aged Patients?
Yuji IwanamiDepartment of Cardiology, Nishiarai Heart Center Hospital, Tokyo 2How to Select a Device: CRT-P or CRT-D in Elderly Patient
Toshiko NakaiFJCSDepartment of Medicine, Division of Cardiology, Nihon University School of Medicine, Tokyo 3Transcatheter Aortic Valve Implantation (TAVI) in Very Old Patients: Not Only Feasible, but also
Reasonable?
Hiroshi UenoThe Second Department of Internal Medicine, University of Toyama, Toyama 4Implications for Clinical Practice of BodyMass Index and Nutritional Index Learned from One-Year
Mortality in Elderly Patients UndergoingMitraClip
Yuki IshibashiDivision of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki
5Destination Therapy in the Super Aging Society
Osamu SeguchiDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita 6Home Based Cardiac Rehabilitation toMaintain Home Time in Elderly Patients with Heart Failure
Tsuyoshi SuzukiDepartment of Home-based Medical Care, Yumino Heart Clinic, Tokyo
Symposium 19 (Arrhythmia)
March 28 (Sun) 800930 Room 18 (F201202, 2F, Annex) Recent Advancement of Non-pharmacological Therapies for Atrial Fibrillation
Chairpersons Teiichi YamaneDivision of Cardiology, The Jikei University School of Medicine, Tokyo Laurent MacleMedicine, Cardiology, Electrophysiology, Montreal Heart Institute Université de Montréal, Montreal, Canada
Keynote Lecture Recent Advancements in Catheter Ablation for Atrial Fibrillation: An Overview
Laurent MacleMedicine, Cardiology, Electrophysiology, Montreal Heart Institute Université de Montréal, Montreal, Canada 1A New Trend in Radiofrequency Catheter Ablation for Atrial Fibrillation Using High-Power Short-
Duration Energy
Koichiro EjimaDepartment of Cardiology, Tokyo Women’s Medical University, Tokyo
March
28
AM
223
2Cryoballoon Ablation in Patients with Persistent AF: Final Results from the Japanese Cohort of the
STOP Persistent AF Study
Michifumi TokudaDepartment of Cardiology, The Jikei University School of Medicine, Tokyo 3Impact of Catheter Ablation of Atrial Fibrillation on Cerebral Blood Flow and Brain Volume
Yoshihide TakahashiDepartment of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo 4The Current Status of Catheter Ablation of Atrial Fibrillation: Analysis of the Japanese Catheter
Ablation (J-AB) Registry
Kengo KusanoFJCSDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita 5Initial Practice of Left Atrial Appendage Closure Device in Japan; Single-Center Experience
Masato FukunagaDepartment of Cardiology, Kokura Memorial Hospital, Kitakyushu 6Is the Left Atrial Appendage Closure Alone Superior to theMaze Procedure for Atrial Fibrillation?
Yosuke IshiiDepartment of Cardiovascular Surgery, Graduate School of Medicine, Nippon Medical School, Tokyo
Symposium 20 (IHD)
March 28 (Sun) 8451015 Room 20 (F205206, 2F, Annex) Vulnerable Plaques and Vulnerable Patients: Up-to-Date
Chairpersons Shiro UemuraFJCSCardiovascular Medicine, Kawasaki Medical School, Kurashiki Ik-Kyung JangCardiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
Keynote Lecture Vulnerable Plaque Research: Current Status and Future
Ik-Kyung JangCardiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA 1OCT-polarimetry for Characterizing Coronary Plaque Vulnerability in Patients
Kenichiro OtsukaDepartment of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka 2Accuracy of Optical Coherence Tomography in Detecting Vulnerable Plaque
Takashi KuboFJCSDepartment of Cardiovascular Medicine, Wakayama Medical University, Wakayama 3Prognostic Links between Coronary Inflammatory Features and Functional Abnormalities in Patients
with Ischemia and Non-Obstructive Coronary Artery Disease (INOCA)
Kensuke NishimiyaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai 4Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-intensity Plaques Detected
with Non-contrast T1-weighted Imaging: Insights from the AQUAMARINE EPA/DHA study
Kazuhiro NakaoDepartment of Cardiovascular Medicine, National Cerebral and Cardiovacular Center, Suita
21 (PDC/Divers/PH)
3 28 9451115 15 4FG414415 Diversity of Cardiologist× FJCS
1Industry-Academia-Government Collaboration Concerning Research and Development in the
Healthcare andMedical Fields in Osaka University
2Behavioral Economics in Cardiovascular Disease
3Collateral-like Path fromMedicine and Tachycardia-inducing Carrier in Business
4Medical Device Development in Japan

22 (Emer/Med Policy/New Fields)
3 28 11001230 3 1FG6 FJCS
1Impact of High Performance Computer Technology on Cardiology
2Medical Device Development Using Advanced Technology toward Smart Surgery
3Japan’s Health ICT Policy about Software, AI, Robot, VR, and Telemedicine

Special Session 36 36 (Emer/Med Policy/New Fields)
3 28 800930 1 1FG7G8 5 3 FJCS
1Japan Stroke Society’s Initiatives in the First Five-Year Plan -Focusing on Stroke Center Certification-
2Emerging EmergencyMedical Care System in the Five-Year Plan for Overcoming Stroke and
Cardiovascular Disease
FJCS 3IdealMedical System for Aortic Emergency
4Cardiac Rehabilitation in Patients with Heart FailureHospital Initiatives FJCS
5Cardiac Rehabilitation with Nutrition Education in Community-based Health Care
Discussants FJCS
Special Session 37 37 (HF/CM)
March 28 (Sun) 800930 Room 11 (G404, 4F, North)
New Treatment Strategies for Cardiomyopathy
Chairpersons Hiroko WakimotoDepartment of Genetics, Harvard Medical School, USA Carolyn Y. HoCardiovascular Medicine, Brigham and Women’s Hospital, USA
1Therapeutic Targets for Dilated Cardiomyopathy
Jianming JiangYong Loo Lin School of Medicine, Singapore 2BET Bromodomain Proteins as Therapeutic Targets in Heart Failure
Michael A. BurkeEmory University School of Medicine, Atlanta, GA, USA 3Hypertrophic Cardiomyopathy in 2021 and Beyond
Carolyn Y. HoBrigham and Women’s Hospital, Boston, USA 4CardiomyocyteMyeloperoxidase as a Novel Therapeutic Target for ImprovingMyocardial Relaxation
Derek J. HausenloyDuke-NUS Medical School, Singapore
March
28
AM
225
Special Session 38 38 (HF/CM)
March 28 (Sun) 800930 Room 15 (G414415, 4F, North)
Cardiomyocyte Function
Chairpersons Seiji TakashimaDepartment of Medical Biochemistry, Osaka University Graduate School of Medicine, Suita Lea M. D. DelbridgeSchool Biomedical Science, University of Melbourne, Melbourne, Australia
Keynote Lecture The Role of Pericardial Adipose in Arrhythmia Provocation -Adipocytokine Involvement
Lea M. D. DelbridgeSchool Biomedical Science, University of Melbourne, Melbourne, Australia 1The Role ofMyosin Right Chain in Cardiac Function
Seiji TakashimaDepartment of Medical Biochemistry, Osaka University, Graduate School of Medicine, Suita 2Mechanobiology of Human Induced Pluripotent Stem Cell Derived CardiomyocytesModels
Beth L. PruittCenter for BioEngineering, Santa Barbara, USA 3Molecular Properties of Cardiac Myosin, Leading to an Understanding of Heart Function
Motoshi KayaGraduate School of Science, University of Tokyo, Tokyo
Special Session 39 39 (IHD)
March 28 (Sun) 800930 Room 19 (F203204, 2F, Annex) How Far Has Ischemic Assessment Progressed with Diversified “Coronary Physiology”?
Chairpersons Hiroyuki OkuraFJCSDepartment of Cardiology, Gifu University Graduate School of Medicine, Gifu William FearonCardiovascular Medicine, Stanford University, USA
Keynote Lecture Ischemia or Anatomy for PredictingMyocardial Infarction
William FearonStanford University, Stanford, USA 1Potency of Pressure-Wire Pullback-Guided PCI for LeftMain Coronary Artery Disease: Insights from
the GRADIENT-Registry, GIFT-Registry, DEFINE-LM Registry, and REFINE-RPG Study
Takayuki WarisawaDepartment of Cardiovascular Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama
2Outcomes after Deferral of Revascularization Based on Fractional Flow Reserve: Lessons from the J-
CONFIRM Registry
Special Session 40 40 (Prev/Rehab)
March 28 (Sun) 9201050 Room 17 (G418419, 4F, North)
Diabetes and Heart Diseases
Chairpersons Ichiro ShiojimaFJCSDepartment of Medicine II, Kansai Medical University, Hirakata Kenneth WalshSchool of Medicine, University of Virginia, USA
Keynote Lecture Clonal Hematopoiesis and Cardio-metabolic Risk
Kenneth WalshUniversity of Virginia, Charlottesville, USA 1Heart Failure and Diabetes: Clinical Relevance and Perspectives in the Prevention and Treatment
Koichiro KuwaharaFJCSDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto 2SkeletalMuscle is a Target Organ to Combat with Diabetes-related Cardiovascular Disorders through
Secretion ofMuscle-derived Factors and miRNAs
Yasuhiro IzumiyaFJCSDepartment of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka
3Role of Insulin Signaling in the Failing Heart
Ippei ShimizuDepartment of Cardiology, Niigata University, Niigata
March
28
AM
226
Special Session 41 41 (HF/CM)
March 28 (Sun) 9451115 Room 13 (G401402, 4F, North)
Global Status and Trend of Prevalence andMedical Care of Heart Failure Worldwide
Chairpersons Masafumi KitakazeFJCSDepartment of Cardiovascular Medicine, Hanwa Daini Senboku Hospital, Sakai Carolyn Su Ping LamDepartment of Cardiology, National Heart Centre Singapore, Duke-NUS Medical School, Singapore
Keynote Lecture Global Differences in Heart Failure with Preserved Ejection Fraction
Carolyn Su Ping LamDepartment of Cardiology, National Heart Centre Singapore, Duke-NUS Medical School, Singapore 1Clinical Characteristics andMedical Care System of the Patients with Heart Failure in Japan: Lessons
from Clinical Registries
Tomomi IdeFJCSDepartment of Cardiovascular Medicine, Kyushu University, Fukuoka 2Global Trends in Interventional Cardiology Certification
Scott D. SolomonCardiovascular Department, Brigham and Women’s Hospital, Harvard Medical School, USA 3Trends in Epidemiology of Heart Failure, and the Need for a Paradigm Shift in Prevention and
Management
Mikhail KosiborodCV Research, Saint Luke’s Mid America Heart Institute, USA
Special Session 42 42 (Basic Res)
March 28 (Sun) 9451115 Room 16 (G416417, 4F, North)
Genetic Cardiovascular Disease -FromMechanism to Phenotype and GWAS
Chairpersons Hiroyuki MoritaFJCSDepartment of Cardiovascular Medicine, The University of Tokyo, Tokyo Jonathan G. SeidmanDepartment of Genetics, Harvard Medical School, USA
Keynote Lecture Human Genetic Approaches to Understanding Inherited Cardiomyopathies
Jonathan G. SeidmanDepartment of Genetics, Harvard Medical School, USA 1Elucidation of theMechanism of KACh Channelopathy, New Stratification of the Disease, and
Development of Treatment
Yoshihiro AsanoFJCSDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita 2Multi-omics Analysis Dissects the Biology of Heart Failure
Seitaro NomuraDepartment of Cardiovascular Medicine, The University of Tokyo, Tokyo 3Complex Genetic Architecture of Coronary Artery Disease Revealed by GWAS andMachine Learning
Kaoru ItoLaboratory for Cardiovascular Genomics and Informatics, RIKEN Center for Integrative Medical Sciences, Yokohama
Special Session 43 43 (PDC/Divers/PH)
3 28 11001230 14 4FG412413 FJCS
1Establishment of the Transitional Care Support System for Congenital Heart Disease: What Will be
Changed by the Basic Law on Countermeasures against Stroke and Cardiovascular Disease?
FJCS 2Initiative Efforts of the Research Committee of JapaneseMinistry of Health, Labor and Welfare
towards Seamless Transition of Patients with Congenital Heart Disease
FJCS 3Career Guidance and Employment Support may Promote Social Independence among Patients with
Congenital Heart Disease
4Transitional Care at Shizuoka Prefecture, on Focusing Patients with Congenital Heart Disease

March
28
AM
227
5Establishment of Health Care System for Patients with Adult Congenital Heart Disease in
Collaboration with Children’s Hospital -NaganoModel

Special Session 44 44 (Basic Res)
3 28 11001230 17 4FG418419 FJCS
Keynote Lecture Molecular Pathogenesis of Cardiomyopathy
1Clinical Significance and Current Situation of Genetic Diagnosis in Hypertrophic and Restrictive
Cardiomyopathies
FJCS 2Genomic Analysis for Dilated Cardiomyopathy and Left Ventricular Non-compaction
FJCS 3How to Utilize the Genetic Information in Arrhythmogenic Right Ventricular Cardiomyopathy
FJCS 4Application of Genome Analysis and Information to Diagnosis and Treatment of Cardiomyopathy
FJCS
Special Session 45 45 (Arrhythmia)
3 28 11001230 18 2FF201202 FJCS
Keynote Lecture Evidence for Risk and Anticoagulant Therapy in the Japanese Elderly Patients
1Clinical Characteristics and Outcomes in Elderly Japanese Patients with Nonvalvular Atrial
Fibrillation -Insights from the Results of Japanese AF Registry-
2Significance of Catheter Ablation for Atrial Fibrillation in Elderly Patients
3Indication of Left Atrial Appendage Closure for Elderly Patients

Special Session 46JCCN 46JCCN(HF/CM)
3 28 11001230 19 2FF203204 2020 Update FJCS
1Imaging for Myocardial Viability: Learning from AHA Scientific Statement
CVIC 2Self-Measured Blood PressureMonitoring at Home
3Low Dose Oral AnticoagulantManagement in Eldery Patients with Atrial Fibrillation Based on
Results of ELDERCARE-AF and ESC Guideline

March
28
AM
228
4Timing of Patient Referral for Atrial Fibrillation Catheter Ablation and Follow-up in Primary Care
Setting
5How Long should We Continue to Treat with Dual Anti-Platelet Therapy after Interventions?
-Antiplatelet Therapy That Primary Care Doctors Struggle for in the Super-aging Society-

(PDC/Divers/PH) 3 28 800900 10 3FG318319 FJCS FJCS
1QT
2QT
3
4CPVT
(IMG)
3 28 11301230 9 3FG316317 TEE-based Intervention to Structural Heart Disease
FJCS
1TAVI perivalvular leakage
2
3
4MitraClip
3 28 9151045 6 3FG301302 6 2021

March
28
AM
229
3 28 11001230 6 3FG301302 7 2021

13 (IHD)
3 28 10301200 20 2FF205206 PCI FJCS FJCS
1“Less isMore” Approaches to Antithrombotics in Atrial Fibrillation Patients with Coronary Artery
Disease
FJCS 2ISCHEMIA Evaluation
3The Role of CABG in the Heart Team
4Recent Trends in Percutaneous Coronary Intervention in Japan
FJCS
14 (Emer/Med Policy/New Fields)
3 28 11001230 12 4FG403
1JCS 2021/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases
FJCS 2Destination Therapy
3SHD advanced care planning FJCS
4 End of Life
5Comprehensive Symptom Assessment Using Integrated Palliative Care Outcome Scale in
Hospitalized Heart Failure Patients

15 (Emer/Med Policy/New Fields)
3 28 800930 2 1FG5 FJCS
1FJCS
March
28
AM
230
2 / 3 4Changes inMyocardial Infarction Treatment System under the COVID19 Pandemic
FJCS 5 6Electrophysiological Procedures under the COVID-19 Pandemic
FJCS
16 (Prev/Rehab)
3 28 800900 12 4FG403 FJCS
1Outline and Points of the Revised Guideline
FJCS 2New Guideline for Remote Cardiac Rehabilitation of JACR 2021
3New Developments in Cardiac Rehabilitation -From 2021 JCS Guidelines: Rehabilitation for Patient
with Aortic Disease-
in Cancer Patients and Survivors-

17 (HF/CM)
3 28 9451045 19 2FF203204
1
2Multifaceted Effects of SGLT2 Inhibitors and Their Therapeutic Targets
3Implication of Natriuretic Peptides in Cardio-Renal Interactions
FJCS 4Decongestion for Heart Failure: Aquaresis

18 (Arrhythmia)
3 28 11301230 10 3FG318319 VT FJCS
1Role of Pharmacotherapy for Ventricular Tachycardia
FJCS 2Utility of the Cardiac Imaging in VTManagement: CT and the LGE-MRI Assessment
3Ablation of Scar-Related Ventricular Tachycardia Guided by Functional SubstrateMapping

March
28
AM
231
4The Role of Anti-tachycardia Pacing against Ventricular Tachycardia in the Current Era -Whether It is
Necessary or Not?-
19 (Prev/Rehab)
3 28 11301230 13 4FG401402
1The Scoring System and Interprofessional Hospital-Community Partnership to Prevent Readmission
in Elderly Patients with Decompensated Heart Failure
2A Trial of New Heart FailureManagement ProgramUsing ICT Tools among Affiliated Hospitals and
Cardiology Clinics in KyotoKyoto Heart Failure Network
3Multidisciplinary TeamMedical Care for Patients with Chronic Heart Failure in the Southwest Area of
Okayama Prefecture
4Home-basedMedical Care for Heart Failure Patients byMultidisciplinary Team Approach in Osaka

16 (IMG)
3 28 9451045 9 3FG316317 MRI
1Cardiovascular Magnetic Resonance Imaging Techniques for Evaluation ofMyocardial Edema: T2-
weighted Imaging and Native T1Mapping
/ 2How toMaintain CMR Throughput without Sacrificing Image Quality: Experience from High-Volume
Imaging Center
CVIC 3Utility of High-quality Cardiac Magnetic Resonance Imaging in theManagement of Non-ischemic
Cardiomyopathies
4The Preparation and Practice for High-Quality LGE

17 (HF/CM)
3 28 9451045 11 4FG404
1Optimal Use of the Endomyocardial Biopsy in Clinical Practice: The Importance of
“Clinicopathological Intervention”
2The Endomyocardial Biopsy Technique at Osaka University Hospital
3Learn about Endomyocardial Biopsy in Daily Clinical Practice

18 (HF/CM)
3 28 11301230 11 4FG404 FJCS
1Various and Specific Pathologic Findings of Cardiac Sarcoidosis in Autopsied Hearts
2Confronting the Diversity of Cardiac Sarcoidosis
3OptimalManagement for Heart Failure in Cardiac Sarcoidosis
4Prognosis and Outcome of “Clinical” and “Isolated” Diagnosis in Cardiac Sarcoidosis
FJCS
19 (Basic Res)
3 28 11301230 16 4FG416417
1Mechanisms of Cardiovascular Cell Differentiation and Development (Introductory Remark)
2Tbx1 Regulates Cell Fate Decisions toward Heart and Branchiomeric Muscles in Pharyngeal
ApparatusMesodermal Cells
Albert Einstein College of Medicine, Bronx, NY, USA/ 3Developmental and Regenerative Biology of Cardiac Stem Cells
4Cutting-edge Researches Implicated in Clinical Cardiovascular Embryology

Late Breaking Cohort Studies 2 (Others)
March 28 (Sun) 9451115 Room 2 (G5, 1F, North)
Chairpersons Ken OkumuraDivision of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto Junya AkoFJCSCardiovascular Medicine, Kitasato University, Tokyo
1Two-year Outcomes of >30,000 Elderly Patients with Atrial Fibrillation: Results from the All Nippon
AF in the Elderly (ANAFIE) Registry
Hiroshi InoueFJCSSaiseikai Toyama Hospital, Toyama Commentator Masaharu AkaoFJCSDepartment of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto
2Percutaneous Coronary Intervention versus Coronary Arterial Bypass Grafting for AcuteMyocardial
Infarction with LeftMain or Multivessel Coronary Disease
Hideki MiyachiTokyo CCU Network Scientific Committee, Tokyo Commentator Hirofumi TakemuraFJCSDepartment of Cardiovascular Surgery, Kanazawa University Graduate School of Medicine, Kanazawa
3Impact of Baseline Left Ventricular Ejection Fraction on Outcomes PostMitraClip Therapy: Real-
world Data ofMulticenter Registry in Japan
Takashi MatsumotoDepartment of Cardiology, Sendai Kousei Hospital, Sendai Commentator Junya AkoFJCSCardiovascular Medicine, Kitasato University, Tokyo
March
28
AM
233
4Prognostic Value of Cardio-ankle Vascular Index as a Marker of Arterial Stiffness for Cardiovascular
Events: the CAVI-J Study
Toru MiyoshiDepartment of Cardiovascular Medicine, Okayama University, Okayama Commentator Hirofumi TomiyamaDepartment of Cardiology, Tokyo Medical University, Tokyo
5Impact of Chronic Kidney Disease on the Association of Soluble Flt-1 with Cardiovascular Events and
Mortality: The EXCEED-J Study
4
3 28 9451100 4 3FG304 FJCS FJCS
FRS4-1 The Current Clinical Burden of Unplanned Hospitalization of Adult Congenital Heart Disease in
Japan
FJCS FRS4-2 Effect of Stress-induced Hyperglycemia on Survival in Acute Coronary Syndrome Patients with
and without Chronic Kidney Disease
FRS4-3 Multiple Arrhythmic and Cardiomyopathic Phenotypes Associated with a Non-functional SCN5
A A735EMutation
FRS4-4 GJA-1 Gene Polymorphism is a Genetic Predictor of Recurrence after Pulmonary Vein Isolation
in Patients with Paroxysmal Atrial Fibrillation
FRS4-5 Prevention of Contrast-Induced Nephropathy after Cardiovascular Catheterization and
Intervention by High Dose Strong Statin Therapy. The PREVENT CINC-J study

5
3 28 11151230 4 3FG304 FJCS
FRS5-1 Clinical Characteristics of Pediatric Brugada Syndrome in Japanese Registry
FRS5-2 Comparisons in Procedural Characteristics of Pulmonary Vein Isolation between High-Power
Short-Duration and Standard Settings
FRS5-3 Utility of Last DeflectionMapping of Slow Pathway Potential for Cryoablation in Slow-fast
Atrioventricular Nodal Reentrant Tachycardia
FRS5-4 Difference in Efficacy of Balloon Pulmonary Angioplasty in Inoperable Chronic
Thromboembolic Pulmonary Hypertension and Residual Pulmonary Hypertension after
Pulmonary Endarterectomy
in Patients with Paradoxical Low-flow Low-gradient Aortic Valve Stenosis: AMulti-center
Analysis
March
28
AM
234
4
3 28 9151045 12 4FG403 FJCS
1
2
3
4
5
6
March
28
AM
235
Luncheon Seminar 38
3 28 12451335 1 1FG7G8 Covid-19a deadly intersection

/
Luncheon Seminar 39
3 28 12451335 2 1FG5 AF


Luncheon Seminar 40
3 28 12451335 3 1FG6 ARNI
1

Luncheon Seminar 41
3 28 12451335 5 3FG303 TAVI

Luncheon Seminar 42
3 28 12451335 6 3FG301302

Luncheon Seminar 43
3 28 12451335 8 3FG314315 DPP4


Luncheon Seminar 44
3 28 12451335 9 3FG316317 2020


/
Luncheon Seminar 45
3 28 12451335 10 3FG318319
1

Luncheon Seminar 46
3 28 12451335 11 4FG404 ×
1multimorbidity
2

Luncheon Seminar 47
3 28 12451335 13 4FG401402 -EPADHA-


Luncheon Seminar 55
3 28 12451335 14 4FG412413
1Minimizing Radiation in Your Transseptal Punctures and Ablations
Rodney HortonTexas Cardiac Arrhythmia Institute, St. David’s Medical Center, USA 2Optimizing Your Transseptal Puncture in LAAC Procedures
Shephal DoshiPacific Heart Institute, USA

Luncheon Seminar 48
3 28 12451335 15 4FG414415 - Impella Heart Pump

Luncheon Seminar 49
3 28 12451335 16 4FG416417
1
2beyond AHI
/
Luncheon Seminar 50
3 28 12451335 17 4FG418419
1 --

/
Luncheon Seminar 51
3 28 12451335 18 2FF201202
1
2 /

Luncheon Seminar 52
3 28 12451335 19 2FF203204


Luncheon Seminar 53
3 28 12451335 20 2FF205206 CAVI-J study